Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?

Publisher： Karger

E-ISSN： 1660-2110|118|4|c380-c383

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.118, Iss.4, 2011-02, pp. : c380-c383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Hypoglycaemic Agents: Considerations in Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 126, Iss. 1, 2014-01 ,pp. : 14-18

Karger

Access to resources Recommend Favorite

Use of metformin in chronic kidney disease should continue to be based on common sense in the absence of an evidence base

By  

DIABETIC MEDICINE, Vol. 32, Iss. 7, 2015-07 ,pp. : 981-982

John Wiley & Sons Inc

Access to resources Recommend Favorite

Managing chronic kidney disease

By Benett Ivan  

British Journal of General Practice, Vol. 60, Iss. 576, 2010-07 ,pp. : 533-533

Royal College of General Practitioners

Access to resources Recommend Favorite

Chronic kidney disease

By de Lusignan Simon  

British Journal of General Practice, Vol. 56, Iss. 532, 2006-11 ,pp. : 885-885

Royal College of General Practitioners

Access to resources Recommend Favorite

Managing chronic kidney disease

By Tisi Roger  

British Journal of General Practice, Vol. 60, Iss. 576, 2010-07 ,pp. : 532-532

Royal College of General Practitioners

Access to resources Recommend Favorite